Improving infection reporting in hematology treatment trials.
作者信息
Teh Benjamin W, Reynolds Gemma K, Mikulska Malgorzata, Mueller Nicolas J, Slavin Monica A
机构信息
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
出版信息
Blood Adv. 2024 Nov 26;8(22):5925-5926. doi: 10.1182/bloodadvances.2024013859.
Abstract
摘要
相似文献
1
Improving infection reporting in hematology treatment trials.
Blood Adv. 2024 Nov 26;8(22):5925-5926. doi: 10.1182/bloodadvances.2024013859.
2
Evidence of selective reporting bias in hematology journals: A systematic review.
PLoS One. 2017 Jun 1;12(6):e0178379. doi: 10.1371/journal.pone.0178379. eCollection 2017.
3
Hematology journals do not sufficiently adhere to reporting guidelines: a systematic review.
J Thromb Haemost. 2017 Apr;15(4):608-617. doi: 10.1111/jth.13637. Epub 2017 Feb 27.
4
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.
Curr Hematol Malig Rep. 2021 Apr;16(2):126-131. doi: 10.1007/s11899-021-00627-3. Epub 2021 Mar 30.
5
Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review.
J Oncol Pharm Pract. 2016 Feb;22(1):105-13. doi: 10.1177/1078155214567163. Epub 2015 Jan 10.
6
Harmonization of interpretative comments in laboratory hematology reporting: the recommendations of the Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC).
Clin Chem Lab Med. 2018 Dec 19;57(1):66-77. doi: 10.1515/cclm-2017-0972.
7
Critical values in hematology of 862 institutions in China.
Int J Lab Hematol. 2017 Oct;39(5):513-520. doi: 10.1111/ijlh.12681. Epub 2017 May 12.
8
Reporting of race and ethnicity at an international haematology conference.
Br J Haematol. 2020 Dec;191(5):e107-e109. doi: 10.1111/bjh.17065. Epub 2020 Aug 30.
9
Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies.
JMIR Mhealth Uhealth. 2021 Jul 8;9(7):e29619. doi: 10.2196/29619.
10
The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative.
Blood Adv. 2025 Feb 25;9(4):687-695. doi: 10.1182/bloodadvances.2024013945.
引用本文的文献
1
Noncanonical and mortality-defining toxicities of CAR T cell therapy.
Nat Med. 2025 Jul 16. doi: 10.1038/s41591-025-03813-5.
2
Trapped in the NETs: Multiple Roles of Platelets in the Vascular Complications Associated with Neutrophil Extracellular Traps.
Cells. 2025 Feb 25;14(5):335. doi: 10.3390/cells14050335.
3
Improving reporting of infection events in clinical trials.
Blood Adv. 2024 Nov 26;8(22):5927-5928. doi: 10.1182/bloodadvances.2024014102.
本文引用的文献
1
Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma.
Blood Adv. 2024 Sep 24;8(18):4979-4982. doi: 10.1182/bloodadvances.2024013461.
2
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis.
Blood Adv. 2024 Jul 9;8(13):3555-3559. doi: 10.1182/bloodadvances.2024012916.
3
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.
Lancet Infect Dis. 2024 Jan;24(1):e59-e68. doi: 10.1016/S1473-3099(23)00377-8. Epub 2023 Sep 6.
4
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.
Blood Adv. 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539.
5
Reporting infectious complications in haematology clinical trials should be improved.
Clin Microbiol Infect. 2019 Dec;25(12):1451-1453. doi: 10.1016/j.cmi.2019.07.024. Epub 2019 Aug 8.
6
Reporting infections in clinical trials of patients with haematological malignancies.
Clin Microbiol Infect. 2019 Dec;25(12):1494-1500. doi: 10.1016/j.cmi.2019.04.029. Epub 2019 May 14.
Zotero 插件